FDA approves Pfizer COVID-19 booster for children

May 17th, 20220 WASHINGTON D.C. — The U.S. Food and Drug Administration (FDA) has announced expanded approval for Pfizer’s COVID-19 booster shot. Now, children ages 5-11 are now eligible for the COVID-19 booster shot made by Pfizer-BioNTech and which is recommended at least five months after the initial two-dose series of the vaccine. The...